Clinical Trial Update: A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Xeloda (capecitabine) as first-line chemotherapy for advanced or metastatic gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED